Marketing-authorisation holder · United States
Abraxis Pharm
23 medicines in 1 country, as authorisation holder.
Group structure
Part of
AbraxisPharmaceutical groupOther companies in the group
United States1
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Medicines
Every medicine in the registers under its name, current ones first.
23 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| BRETYLIUM TOSYLATE100MG/ML | 50MG/ML | 50MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Injectable | Bretylium tosilate | United States | Not marketed | 1986 |
| CALCIUM GLUCEPTATE90mg calcium/5ml · Injectable | Gluceptate | United States | Not marketed | 1970 |
| CEPHAPIRIN SODIUM1gm base/vial | 20gm base/vial | 2gm base/vial | 4gm base/vial | 500mg base/vial · Injectable | Cephapirin | United States | Not marketed | 1987 |
| CHLORPROMAZINE HYDROCHLORIDE25mg/ml · Injectable | Chlorpromazine | United States | Marketed | 1974 |
| CHROMIC CHLORIDE0.004mg chromium/ml · Injectable | Chromic | United States | Marketed | 1987 |
| CUPRIC SULFATE0.4MG COPPER/ML | 0.4MG COPPER/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Injectable | Cupric | United States | Marketed | 1987 |
| DEXAMETHASONE10mg phosphate/ml | 4mg phosphate/ml · Injectable | Dexamethasone | United States | Not marketed | 1984 |
| DIAZOXIDE15mg/ml · Injectable | Diazoxide | United States | Not marketed | |
| FLUOROURACIL1GM/20ML (50MG/ML) | 2.5GM/50ML (50MG/ML) | 2.5GM/50ML (50MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 500MG/10ML (50MG/ML) | 500MG/10ML (50MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 50MG/ML | 5GM/100ML (50MG/ML) · Injectable | Fluorouracil | United States | Marketed | 1962 |
| HYDROCORTISONE SODIUM SUCCINATE100mg base/vial | 1gm base/vial | 250mg base/vial | 500mg base/vial · Injectable | Hydrocortisone | United States | Marketed | 1981 |
| LEUCOVORIN CALCIUM100MG BASE/VIAL | 100MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 200MG BASE/VIAL | 350MG BASE/VIAL | 350MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 500MG BASE/VIAL | 50MG BASE/VIAL | 50MG BASE/VIAL **Federal Register deter · Injectable | Calcium folinate | United States | Marketed | 1952 |
| LIDOCAINE HYDROCHLORIDE0.5% | 1.5% | 1% | 10% | 1gm/vial | 2% | 20% | 2gm/vial | 4% · Injectable | Lidocaine | United States | Marketed | 1972 |
| M.V.C. 9+310mg/ml; 0.006mg/ml; 0.5mcg/ml; 1.5mg/ml; 20 iu/ml; 0.04mg/ml; 4mg/ml; 0.4mg/ml; 5'-phosphate sodium 0.36mg/ml; 0.3mg/ml; 330 units/ml; 1 iu/ml · Injectable | Ascorbic acid, Biotin, Vitamin b12, Dexpanthenol, Ergocalciferol, Folic acid, Niacinamide, Vitamin b6, Vitamin b2, Vitamin b1, Vitamin a, Vitamin e | United States | Not marketed | 1981 |
| MANGANESE SULFATE0.1MG MANGANESE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Injectable | Manganese | United States | Not marketed | 1987 |
| METARAMINOL BITARTRATE10mg base/ml | 20mg base/ml · Injectable | Metaraminol | United States | Marketed | 1972 |
| METHYLPREDNISOLONE SODIUM SUCCINATE125mg base/vial | 1gm base/vial | 2gm base/vial | 40mg base/vial | 500mg base/vial · Injectable | Methylprednisolone | United States | Marketed | 1980 |
| METRONIDAZOLE HYDROCHLORIDE500mg base/vial · Injectable | Metronidazole | United States | Not marketed | |
| NALBUPHINE10mg/ml (10mg/ml) | 200mg/10ml (20mg/ml) | 20mg/ml (20mg/ml) · Solution | Nalbufine | United States | Not marketed | 1986 |
| POTASSIUM CHLORIDE1.5meq/ml | 1meq/ml | 2.4meq/ml | 2meq/ml | 3.2meq/ml | 3meq/ml | 4meq/ml · Injectable | Potassium chloride | United States | Marketed | 1971 |
| RITODRINE HYDROCHLORIDE10mg/ml | 15mg/ml · Injectable | Ritodrine | United States | Not marketed | 1987 |
| SODIUM CHLORIDE 23.4% IN PLASTIC CONTAINER234MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Injectable | Sodium chloride | United States | Not marketed | |
| SULFAMETHOXAZOLE AND TRIMETHOPRIM80mg/ml; 16mg/ml · Injectable | Sulfamethoxazole, Trimethoprim | United States | Marketed | 1987 |
| ZINC SULFATE1mg zinc/ml · Injectable | Zinc | United States | Not marketed | 1987 |